FdaApplication
ANDA 205329
Identifiers
- fda_app_no: ANDA205329
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2018-09-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVONORGESTREL | LEVONORGESTREL | 1.5MG | TABLET;ORAL |
1 product